Biocon is currently trading at Rs. 290.80, up by 0.35 points or 0.12% from its previous closing of Rs. 290.45 on the BSE.
The scrip opened at Rs. 293.80 and has touched a high and low of Rs. 293.80 and Rs. 290.20 respectively. So far 34283 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 341.43 on 25-Jan-2019 and a 52 week low of Rs. 211.30 on 20-Aug-2019.
Last one week high and low of the scrip stood at Rs. 293.80 and Rs. 279.75 respectively. The current market cap of the company is Rs. 34860.00 crore.
The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 21.64% and 17.70% respectively.
US Food and Drug Administration (USFDA) has completed Pre-Approval inspection at Biocon’s subsidiary -- Biocon Pharma’s Oral Solid Dosage manufacturing facility with Zero Observations. The inspection of the Bengaluru facility, which took place between January 13 and January 17, 2020, concluded with zero observations and no Form 483 was issued
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.
Watch our Stock Market Target Calls Quality, Track sheet – Click Here or Subscribe us for Stock Market Trading >>>> Stock Cash Tips
No comments:
Post a Comment